A preliminary investigation of cognitive function in rheumatoid arthritis patients on long-term methotrexate treatment

J Health Psychol. 2013 Oct;18(10):1353-9. doi: 10.1177/1359105312461660. Epub 2012 Nov 26.

Abstract

Some studies suggest that cognitive function is impaired in rheumatoid arthritis patients. One possible influence may be commonly used rheumatoid arthritis treatment, methotrexate. This study examined cognitive function in long-term methotrexate users with rheumatoid arthritis and, using a 24-hour pre- and post-methotrexate dose administration, investigated whether there may be transient cognitive function changes. Rheumatoid arthritis patients (n = 35) were assessed immediately before taking methotrexate and 24 hours later. Low and high methotrexate dose groups were then compared. Cognitive performance was unchanged across two assessment points and was within the normal range, although lower in high methotrexate dose group.

Keywords: cognitive function; drug effects; memory; methotrexate; rheumatoid arthritis.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / psychology
  • Cognition / drug effects*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Male
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Neuropsychological Tests
  • Time Factors

Substances

  • Antirheumatic Agents
  • Methotrexate